| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 07/21/2005 | WO2005065683A1 Triazole, oxadiazole and thiadiazole derivative as ppar modulators for the treatment of diabetes |
| 07/21/2005 | CA2549385A1 Triazole, oxadiazole and thiadiazole derivative as ppar modulators for the treatment of diabetes |
| 07/20/2005 | EP1554361A1 Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/19/2005 | US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| 07/14/2005 | WO2005063742A2 Amidino compounds as cysteine protease inhibitors |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063690A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 07/14/2005 | WO2005040142B1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/14/2005 | WO2005013888A3 Compounds, compositions and methods |
| 07/14/2005 | US20050154211 Reacting carboxy nitriles with hydroxylamine salts, then anhydriding the chemical intermediates and cyclization to form nitrogen compounds such as ethyl 5-(2-((t-butoxy)carbonyl amino)ethyl)-1,2,4-oxadiazole-3-carboxylate |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050153996 Compounds that modulate ppar activity and methods for their preparation |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | CN1639141A New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 07/13/2005 | CN1639137A Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxadiazol-2-ones, the production thereof and their use in medicaments |
| 07/13/2005 | CN1639115A Semicarbazide derivatives and their use as antithrombotics |
| 07/13/2005 | CN1638766A Use of substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/06/2005 | EP1549624A2 Inhibitors of fatty acid amide hydrolase |
| 07/06/2005 | EP1549306A1 Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058868A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | WO2005058848A1 (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058311A1 Heterocyclic aspartyl protease inhibitors |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | CA2549825A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2548388A1 Heterocyclic aspartyl protease inhibitors |
| 06/30/2005 | CA2547198A1 (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/29/2005 | CN1208327C Process for preparing S, Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137200 Potassium channel modulators; antiarrhythmia agents |
| 06/23/2005 | US20050137168 inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor; for treatment and/or prevention of arterial and venous thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina pectoris, cardiac infarction, stroke |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/21/2005 | US6908937 Heterocyclic fluoroalkenyl thioethers (II) |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908492 Cationic hair dyes; colorfastness, photostability |
| 06/16/2005 | WO2005032550A3 Peptide deformylase inhibitors |
| 06/16/2005 | WO2005003081A3 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | US6906006 Applying to plants, environment |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/09/2005 | WO2005051932A1 Arylheterocycle derivative and agricultural or horticulrual bactericide and insecticide |
| 06/09/2005 | WO2005040142A9 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 06/09/2005 | US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease |
| 06/08/2005 | EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 06/08/2005 | EP1536790A2 Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 06/08/2005 | EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1373231B1 3-heterocyclyl-propano-hydroxamic acid as pcp inhibitors |
| 06/08/2005 | EP0849256B1 Amide compounds and use of the same |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/07/2005 | US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker |
| 06/02/2005 | US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| 06/02/2005 | US20050119316 Semicarbazide derivatives and the use thereof as antithrombotics |
| 06/02/2005 | US20050119312 Lipid lowering agents; hypotensive agents; obesity |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534671A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 06/01/2005 | EP1534259A2 Sulfonamides as potassium channel blockers |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/31/2005 | US6900233 Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/31/2005 | US6900207 N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient |
| 05/26/2005 | US20050113451 7-acetamidinyl derivatives |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113428 2-{3,5-bis[(3-chlorobenzyl)oxy]benzyl}-1,2,4-oxadiazolidine-3,5-dione to treat disorders associated with elevated PAI-1(Plasminogen activator inhibitor) levels |
| 05/26/2005 | US20050112407 Organic electroluminescent device |
| 05/25/2005 | EP1533292A1 Dibenzylamine compound and medicinal use thereof |
| 05/25/2005 | EP1531810A2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/24/2005 | US6897306 3-heterocyclylpropanohydroxamic acids |
| 05/24/2005 | US6897237 MMP-12 inhibitors |
| 05/24/2005 | US6897220 Antiproliferative agents |
| 05/24/2005 | CA2155840C Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
| 05/19/2005 | US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 05/19/2005 | US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/19/2005 | US20050107354 Preventive or therapeutic agent for kidney disease |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1617850A Dibenzylamine compound and medicinal use thereof |
| 05/18/2005 | CN1616592A White light-emitting compound, process for producing the same, and luminescent element utilizing the same |
| 05/18/2005 | CN1202095C Heteroaromatic ring compounds |
| 05/18/2005 | CN1202094C 1,2,4-oxdiazoline containing substituent of aryl group in 3 position and its solid phase synthesis method |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894054 Central nervous system disorders; muscular disorders |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |